Skip to main content
Clinical Trials/NL-OMON28204
NL-OMON28204
Not yet recruiting
Not Applicable

Pilot study on the determination of tumor concentrations of protein kinase inhibitors in patients with newly diagnosed high-grade glioma

VU University Medical CenterDe Boelelaan 117, 1081 HV Amsterdam 0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Targeted TherapyHigh-grade gliomaKinase inhibitorAngiogenesis Targeted therapieHooggradig glioomKinase remmerAngiogenese
Sponsor
VU University Medical CenterDe Boelelaan 117, 1081 HV Amsterdam
Enrollment
15
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
VU University Medical CenterDe Boelelaan 117, 1081 HV Amsterdam

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients without a history of brain tumor
  • 2\. Initial brain MR\-scan suggesting a high grade glioma, according to the interpretation of an expert neuroradiologist

Exclusion Criteria

  • 1\. Patients receiving prior chemotherapy, radiotherapy or anti\-angiogenic therapy
  • 2\. Use of anti\-coagulant therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials